Immatics (IMTX) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart

IMTX Stock Forecast

Immatics stock forecast is as follows: an average price target of $22.00 (represents a 221.17% upside from IMTX’s last price of $6.85) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

IMTX Price Target

The average price target for Immatics (IMTX) is $22.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $28.00 to $16.00. This represents a potential 221.17% upside from IMTX's last price of $6.85.

IMTX Analyst Ratings

Buy

According to 2 Wall Street analysts, Immatics's rating consensus is 'Buy'. The analyst rating breakdown for IMTX stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Immatics Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
May 16, 2024	Graig Suvannavejh	Mizuho Securities	$16.00	$11.08	44.40%	133.58%
Aug 09, 2022	Geulah Livshits	Chardan Capital	$28.00	$12.43	125.26%	308.76%

The latest Immatics stock forecast, released on May 16, 2024 by Graig Suvannavejh from Mizuho Securities, set a price target of $16.00, which represents a 44.40% increase from the stock price at the time of the forecast ($11.08), and a 133.58% increase from IMTX last price ($6.85).

Immatics Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	1
Avg Price Target	-	-	$16.00
Last Closing Price	$6.85	$6.85	$6.85
Upside/Downside	-100.00%	-100.00%	133.58%

In the current month, the average price target of Immatics stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Immatics's last price of $6.85. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Nov 18, 2024	Bank of America Securities	Buy	Buy	Hold
Oct 07, 2024	Piper Sandler		Overweight	Initialise

Immatics's last stock rating was published by Bank of America Securities on Nov 18, 2024. The company gave IMTX a "Buy" rating, the same as its previous rate.

Immatics Financial Forecast

Immatics Revenue Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Jun 20
Revenue	-	-	-	-	-	-	-	-	-	-	-	$9.80M	$37.65M	$15.06M	$17.21M	$102.91M	$15.73M	$6.44M	$5.19M	$7.40M	$9.45M	$6.90M
Avg Forecast	$14.43M	$14.43M	$18.32M	$17.89M	$15.08M	$15.86M	$13.40M	$20.53M	$13.83M	$10.92M	$20.43M	$11.91M	$23.55M	$162.16M	$10.27M	$10.79M	$8.83M	$8.59M	$7.83M	$7.30M	$5.75M	$6.36M
High Forecast	$14.43M	$14.43M	$18.32M	$17.89M	$15.08M	$19.85M	$13.84M	$21.28M	$21.17M	$11.10M	$20.43M	$11.91M	$23.55M	$162.16M	$10.27M	$10.79M	$8.83M	$8.59M	$7.83M	$7.30M	$5.75M	$7.65M
Low Forecast	$14.43M	$14.43M	$18.32M	$17.89M	$15.08M	$12.49M	$12.95M	$19.78M	$6.49M	$10.73M	$20.43M	$11.91M	$23.55M	$162.16M	$10.27M	$10.79M	$8.83M	$8.59M	$7.83M	$7.30M	$5.75M	$4.07M
# Analysts	1	1	1	1	2	4	2	2	4	2	2	2	1	1	1	3	4	4	4	4	4	5
Surprise %	-	-	-	-	-	-	-	-	-	-	-	0.82%	1.60%	0.09%	1.68%	9.54%	1.78%	0.75%	0.66%	1.01%	1.64%	1.08%

Immatics's average Quarter revenue forecast for Jun 23 based on 2 analysts is $20.43M, with a low forecast of $20.43M, and a high forecast of $20.43M. IMTX's average Quarter revenue forecast represents a 108.59% increase compared to the company's last Quarter revenue of $9.80M (Mar 23).

Immatics EBITDA Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Jun 20
# Analysts	1	1	1	1	2	4	2	2	4	2	2	2	1	1	1	3	4	4	4	4	4	5
EBITDA	-	-	-	-	-	-	-	-	-	-	-	$-22.36M	$10.46M	$-19.44M	$-14.82M	$70.13M	$-15.33M	$-25.34M	$-22.50M	$-20.40M	$-21.53M	$-17.64M
Avg Forecast	$-10.71M	$-10.71M	$-13.60M	$-13.27M	$-11.19M	$-11.77M	$-9.94M	$-15.24M	$-10.26M	$-8.10M	$-15.16M	$-8.84M	$-17.48M	$-121.03M	$-7.66M	$-8.05M	$-6.59M	$-6.41M	$-5.84M	$-5.45M	$-4.29M	$-4.75M
High Forecast	$-10.71M	$-10.71M	$-13.60M	$-13.27M	$-11.19M	$-9.27M	$-9.61M	$-14.68M	$-4.82M	$-7.96M	$-15.16M	$-8.84M	$-17.48M	$-121.03M	$-7.66M	$-8.05M	$-6.59M	$-6.41M	$-5.84M	$-5.45M	$-4.29M	$-3.04M
Low Forecast	$-10.71M	$-10.71M	$-13.60M	$-13.27M	$-11.19M	$-14.73M	$-10.27M	$-15.79M	$-15.71M	$-8.24M	$-15.16M	$-8.84M	$-17.48M	$-121.03M	$-7.66M	$-8.05M	$-6.59M	$-6.41M	$-5.84M	$-5.45M	$-4.29M	$-5.71M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	2.53%	-0.60%	0.16%	1.93%	-8.71%	2.33%	3.96%	3.85%	3.74%	5.02%	3.72%

2 analysts predict IMTX's average Quarter EBITDA for Mar 23 to be $-8.84M, with a high of $-8.84M and a low of $-8.84M. This is -184.44% lower than Immatics's previous annual EBITDA (Dec 22) of $10.46M.

Immatics Net Income Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Jun 20
# Analysts	1	1	1	1	2	4	2	2	4	2	2	2	1	1	1	3	4	4	4	4	4	5
Net Income	-	-	-	-	-	-	-	-	-	-	-	$-15.12M	$-13.26M	$-20.93M	$-13.98M	$85.66M	$-17.51M	$-31.41M	$-24.23M	$-19.36M	$-25.15M	$-22.77M
Avg Forecast	$-30.60M	$-30.60M	$-27.54M	$-25.50M	$-32.35M	$-26.51M	$-29.87M	$-21.73M	$-34.00M	$-38.42M	$-26.08M	$-28.70M	$-7.92M	$206.11M	$-39.19M	$-32.61M	$-35.85M	$-32.87M	$-33.21M	$-26.96M	$-16.38M	$-15.57M
High Forecast	$-30.60M	$-30.60M	$-27.54M	$-25.50M	$-32.35M	$-21.60M	$-29.87M	$-21.73M	$-27.36M	$-38.42M	$-26.08M	$-28.70M	$-7.92M	$206.11M	$-39.19M	$-32.61M	$-35.85M	$-32.87M	$-33.21M	$-26.96M	$-16.38M	$-13.74M
Low Forecast	$-30.60M	$-30.60M	$-27.54M	$-25.50M	$-32.35M	$-36.33M	$-29.87M	$-21.73M	$-39.80M	$-38.42M	$-26.08M	$-28.70M	$-7.92M	$206.11M	$-39.19M	$-32.61M	$-35.85M	$-32.87M	$-33.21M	$-26.96M	$-16.38M	$-19.23M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	0.53%	1.68%	-0.10%	0.36%	-2.63%	0.49%	0.96%	0.73%	0.72%	1.54%	1.46%

Immatics's average Quarter net income forecast for Jun 22 is $-39.19M, with a range of $-39.19M to $-39.19M. IMTX's average Quarter net income forecast represents a -145.75% decrease compared to the company's last Quarter net income of $85.66M (Mar 22).

Immatics SG&A Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Jun 20
# Analysts	1	1	1	1	2	4	2	2	4	2	2	2	1	1	1	3	4	4	4	4	4	5
SG&A	-	-	-	-	-	-	-	-	-	-	-	$9.59M	$9.74M	$8.42M	$8.68M	$9.28M	$8.84M	$8.27M	$8.27M	$8.43M	$8.70M	$10.08M
Avg Forecast	$10.45M	$10.45M	$13.27M	$12.95M	$10.92M	$11.48M	$9.70M	$14.86M	$10.01M	$7.90M	$14.79M	$8.62M	$17.05M	$117.40M	$7.43M	$7.81M	$6.39M	$6.22M	$5.67M	$5.29M	$4.16M	$4.61M
High Forecast	$10.45M	$10.45M	$13.27M	$12.95M	$10.92M	$14.37M	$10.02M	$15.41M	$15.33M	$8.04M	$14.79M	$8.62M	$17.05M	$117.40M	$7.43M	$7.81M	$6.39M	$6.22M	$5.67M	$5.29M	$4.16M	$5.54M
Low Forecast	$10.45M	$10.45M	$13.27M	$12.95M	$10.92M	$9.04M	$9.38M	$14.32M	$4.70M	$7.77M	$14.79M	$8.62M	$17.05M	$117.40M	$7.43M	$7.81M	$6.39M	$6.22M	$5.67M	$5.29M	$4.16M	$2.95M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	1.11%	0.57%	0.07%	1.17%	1.19%	1.38%	1.33%	1.46%	1.60%	2.09%	2.19%

Immatics's average Quarter SG&A projection for Jun 23 is $14.79M, based on 2 Wall Street analysts, with a range of $14.79M to $14.79M. The forecast indicates a 54.33% rise compared to IMTX last annual SG&A of $9.59M (Mar 23).

Immatics EPS Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Jun 20
# Analysts	1	1	1	1	2	4	2	2	4	2	2	2	1	1	1	3	4	4	4	4	4	5
EPS	-	-	-	-	-	-	-	-	-	-	-	$-0.20	$-0.20	$-0.32	$-0.22	$1.36	$-0.28	$-0.50	$-0.39	$-0.31	$-0.40	$-0.36
Avg Forecast	$-0.29	$-0.29	$-0.26	$-0.24	$-0.31	$-0.25	$-0.28	$-0.20	$-0.32	$-0.36	$-0.25	$-0.27	$-0.07	$2.00	$-0.38	$-0.32	$-0.35	$-0.32	$-0.32	$-0.26	$-0.16	$-0.15
High Forecast	$-0.29	$-0.29	$-0.26	$-0.24	$-0.31	$-0.20	$-0.28	$-0.20	$-0.26	$-0.36	$-0.25	$-0.27	$-0.07	$2.00	$-0.38	$-0.32	$-0.35	$-0.32	$-0.32	$-0.26	$-0.16	$-0.13
Low Forecast	$-0.29	$-0.29	$-0.26	$-0.24	$-0.31	$-0.34	$-0.28	$-0.20	$-0.38	$-0.36	$-0.25	$-0.27	$-0.07	$2.00	$-0.38	$-0.32	$-0.35	$-0.32	$-0.32	$-0.26	$-0.16	$-0.19
Surprise %	-	-	-	-	-	-	-	-	-	-	-	0.74%	2.68%	-0.16%	0.58%	-4.30%	0.81%	1.57%	1.21%	1.18%	2.52%	2.38%

According to 1 Wall Street analysts, Immatics's projected average Quarter EPS for Jun 22 is $-0.38, with a low estimate of $-0.38 and a high estimate of $-0.38. This represents a -127.96% decrease compared to IMTX previous annual EPS of $1.36 (Mar 22).

Immatics Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
ALXO	ALX Oncology	$1.79	$24.50	1268.72%	Buy
KROS	Keros Therapeutics	$18.00	$102.00	466.67%	Buy
AVTE	Aerovate Therapeutics	$2.56	$13.00	407.81%	Hold
BCAB	BioAtla	$1.31	$5.00	281.68%	Buy
IMTX	Immatics	$7.18	$22.00	206.41%	Buy
FENC	Fennec Pharmaceuticals	$6.07	$15.75	159.47%	Buy
MLYS	Mineralys Therapeutics	$12.35	$30.00	142.91%	Buy
SNDX	Syndax Pharmaceuticals	$13.63	$31.67	132.36%	Buy
MRUS	Merus	$44.90	$81.25	80.96%	Buy
REPL	Replimune Group	$11.72	$19.00	62.12%	Buy
LYEL	Lyell Immunopharma	$0.65	$1.00	53.85%	Hold
EWTX	Edgewise Therapeutics	$30.17	$46.25	53.30%	Buy
HRMY	Harmony Biosciences	$33.63	$48.00	42.73%	Buy
CRNX	Crinetics Pharmaceuticals	$55.37	$69.00	24.62%	Buy
JANX	Janux Therapeutics	$59.61	$70.25	17.85%	Buy
KRON	Kronos Bio	$0.96	$1.00	4.17%	Buy

IMTX Forecast FAQ

Is Immatics a good buy?

Yes, according to 2 Wall Street analysts, Immatics (IMTX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of IMTX's total ratings.

What is IMTX's price target?

Immatics (IMTX) average price target is $22 with a range of $16 to $28, implying a 221.17% from its last price of $6.85. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Immatics stock go up soon?

According to Wall Street analysts' prediction for IMTX stock, the company can go up by 221.17% (from the last price of $6.85 to the average price target of $22), up by 308.76% based on the highest stock price target, and up by 133.58% based on the lowest stock price target.

Can Immatics stock reach $10?

IMTX's average twelve months analyst stock price target of $22 supports the claim that Immatics can reach $10 in the near future.

What are Immatics's analysts' financial forecasts?

Immatics's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $64.87M (high $70.06M, low $60.3M), average EBITDA is $-48.139M (high $-44.75M, low $-51.991M), average net income is $-110M (high $-106M, low $-120M), average SG&A $46.97M (high $50.72M, low $43.66M), and average EPS is $-1.042 (high $-0.996, low $-1.135). IMTX's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $65.07M (high $65.07M, low $65.07M), average EBITDA is $-48.292M (high $-48.292M, low $-48.292M), average net income is $-114M (high $-114M, low $-114M), average SG&A $47.11M (high $47.11M, low $47.11M), and average EPS is $-1.078 (high $-1.078, low $-1.078).

Did the IMTX's actual financial results beat the analysts' financial forecasts?

Based on Immatics's last annual report (Dec 2022), the company's revenue was $172.83M, which missed the average analysts forecast of $206.76M by -16.41%. Apple's EBITDA was $46.34M, missing the average prediction of $-154M by -130.05%. The company's net income was $37.51M, missing the average estimation of $126.4M by -70.32%. Apple's SG&A was $36.12M, missing the average forecast of $149.7M by -75.87%. Lastly, the company's EPS was $0.56, missing the average prediction of $1.23 by -54.41%. In terms of the last quarterly report (Mar 2023), Immatics's revenue was $9.8M, missing the average analysts' forecast of $11.91M by -17.74%. The company's EBITDA was $-22.365M, beating the average prediction of $-8.837M by 153.08%. Immatics's net income was $-15.123M, missing the average estimation of $-28.703M by -47.31%. The company's SG&A was $9.59M, beating the average forecast of $8.62M by 11.18%. Lastly, the company's EPS was $-0.2, missing the average prediction of $-0.271 by -26.13%